Digoxin vs Yttrium Y 90 Ibritumomab Tiuxetan
Digoxin vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview
This comparison examines the pharmacological differences between Digoxin and Yttrium Y 90 Ibritumomab Tiuxetan.
Mechanism of Action
Digoxin: Inhibits Na+/K+-ATPase, increasing intracellular calcium.
Pharmacokinetics
Half-life: Digoxin β 36-48 hours.
Chemical Properties
Molecular Formula: Digoxin β C41H64O14.
Molecular Weight: Digoxin β 780.9430 g/mol.
Type: Digoxin β Small molecule; Yttrium Y 90 Ibritumomab Tiuxetan β Antibody.